Prevention of HIV-1 transmission through breastfeeding: efficacy and safety of maternal antiretroviral therapy versus infant nevirapine prophylaxis for duration of breastfeeding in HIV-1-infected women with high CD4 cell count (IMPAACT PROMISE): a randomized, open label, clinical trial.
Loading...
Date
2018
Journal Title
Journal ISSN
Volume Title
Publisher
Wolters Kluwer.
Abstract
Abstract available in pdf.
Description
CAPRISA, 2018.
Keywords
Breastfeeding., HIV-1., Prevention of perinatal HIV-1 transmission., Antiretroviral therapy (ART)., Nevirapine.
Citation
Flynn, P.M., Taha, T.E., Cababasay, M., Fowler, M.G., Mofenson, L.M., Owor, M., Fiscus, S., Stranix-Chibanda, L., Coutsoudis, A., Gnanashanmugam, D., Chakhtoura, N., McCarthy, K., Mukuzunga, C., Makanani, B., Moodley, D., Nematadzira, T., Kusakara, B., Patil, S., Vhembo, T., Bobat, R., Mmbaga, B.T., Masenya, M., Nyati, M., Theron, G., Mulenga, H., Butler, K. and Shapiro, D.E. 2018. Prevention of HIV-1 transmission through breastfeeding: Efficacy and safety of maternal antiretroviral therapy versus infant nevirapine prophylaxis for duration of breastfeeding in HIV-1-infected women with high CD4 cell count (IMPAACT PROMISE): a randomized, open label, clinical trial. Journal of acquired immune deficiency syndromes 77(4), 383-392.